Max Eggersdorfer is a process engineer by training who earned his PhD at ETH Zürich and completed a postdoctoral fellowship in the Weitz lab at Harvard University, blending numerical simulation with hands on experimentation. He joined Novartis in Basel and currently serves as Director Data Science within PHAD, where he advances scientific modeling and data driven formulation development of synthetic molecules across Technical Research & Development.